Proteomics

Dataset Information

0

Nano-LC-MS/MS proteomics in amniotic fluid from CAKUT patients


ABSTRACT: The objective of the present work was to identify new renal proteins responsible for Congenital Anomalies of the Kidney and of the Urinary Tract (CAKUT pathophysiology). We conducted a comparative LC-MS/MS-based proteomics analysis of amniotic fluids (AF) collected from non-severe CAKUT (ns-CAKUT; n=19), severe CAKUT (s-CAKUT; n=14), and healthy controls (cont; n=22) fetuses. We identified a total of 224 gestational age independent proteins that were significantly different in abundance when comparing (one-way ANOVA corrected p<0.05) the 3 groups of amniotic fluids 2 by 2. We identified 8 gestational-age independent proteins that were in common when comparing the 3 groups two by two, and that were considered as associated to both CAKUT onset and CAKUT severity.

INSTRUMENT(S): Orbitrap Fusion

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Amniotic Fluid, Embryonic Stem Cell

DISEASE(S): Cakut

SUBMITTER: Mylène CAMUS  

LAB HEAD: Joost-Peter Schanstra

PROVIDER: PXD022926 | Pride | 2023-09-26

REPOSITORIES: Pride

altmetric image

Publications


Congenital anomalies of the kidney and the urinary tract (CAKUT) are the first cause of chronic kidney disease in childhood. Several genetic and environmental origins are associated with CAKUT, but most pathogenic pathways remain elusive. Considering the amniotic fluid (AF) composition as a proxy for fetal kidney development, we analyzed the AF proteome from non-severe CAKUT (n = 19), severe CAKUT (n = 14), and healthy control (n = 22) fetuses using LC-MS/MS. We identified 471 significant protei  ...[more]

Similar Datasets

2023-10-24 | PXD043519 | Pride
2021-02-01 | GSE143193 | GEO
2016-09-01 | GSE83556 | GEO
2020-07-03 | GSE133824 | GEO
2009-05-21 | E-GEOD-16176 | biostudies-arrayexpress
2022-05-25 | PXD029105 | Pride
2016-11-16 | E-MTAB-4738 | biostudies-arrayexpress
2013-04-23 | E-GEOD-46286 | biostudies-arrayexpress
| PRJNA539971 | ENA
2022-04-04 | PXD028895 | Pride